NIHR i4i & OLS Real World Evidence Programme briefing
Posted:
The NIHR i4i Programme, in collaboration with the Office for Life Sciences (OLS) and the National Institute for Health and Care Excellence (NICE), invites applications to the NIHR i4i & OLS Real World Evidence Programme.
An online launch event will be held 10:30am-12pm on Tuesday 23 January, please register via eventbrite to attend.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us